Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $42.67 Consensus Price Target from Analysts
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have earned an average recommendation of “Hold” from the twelve ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, four have assigned a buy recommendation and […]
26 Mar 06:04 · The Markets Daily